Oral GLP-1 Providers Comparison Table
32 telehealth providers offering oral GLP-1 form factors — oral dissolving tablet (ODT), sublingual, troche, lozenge, or oral compounded — alongside or instead of injectable. For patients who prefer non-injectable delivery. Last updated 2026-05-19.
Important evidence caveat
Compounded oral GLP-1 forms (ODT, sublingual, troche, tablet) have a weaker evidence base than injectable. No STEP/SURMOUNT-equivalent randomized trials of oral compounded semaglutide or tirzepatide exist. The FDA-approved oral GLP-1 for weight loss is Foundayo (orforglipron) — a different small-molecule chemistry than the compounded peptide forms most providers in this table sell. Patients accepting oral compounded options should understand the evidence gap. See our research article on what is orforglipron / Foundayo for the FDA-approved oral pathway.
| # | Provider | Compounded Semaglutide | Compounded Tirzepatide | States served | Named pharmacy | LegitScript | Verification |
|---|---|---|---|---|---|---|---|
| 1 | Strut Health | $99/mo | $199/mo | 49 states | Not disclosed | — | medium |
| 2 | Try Ageless | $119/mo | $169/mo | Not disclosed | Not disclosed | ID 123956 | medium |
| 3 | Ark Health | $125/mo | $249/mo | Not disclosed | 503A/B (unnamed) | — | medium |
| 4 | Velvet Rx | $139/mo | $199/mo | Not disclosed | Not disclosed | — | medium |
| 5 | TeleHealth Med | $147/mo | — | Not disclosed | 503A/B (unnamed) | Certified | medium |
| 6 | Curex | $149/mo | $199/mo | 45 states | Not disclosed | Certified | high |
| 7 | OnlineSemaglutide.org | $150/mo | $399/mo | Not disclosed | Not disclosed | — | medium |
| 8 | Elevated Health | $176/mo | $238/mo | Not disclosed | Not disclosed | — | medium |
| 9 | Claya | $179/mo | $279/mo | Not disclosed | Yes (named) | — | medium |
| 10 | Vaylen | $179/mo | $239/mo | All 50 | Not disclosed | Certified | high |
| 11 | Eve | $195/mo | $195/mo | Not disclosed | 503A/B (unnamed) | ID 42862417 | medium |
| 12 | BetterMe Rx | $199/mo | $299/mo | All 50 | Not disclosed | — | high |
| 13 | FuturHealth | $199/mo | — | Not disclosed | Not disclosed | — | medium |
| 14 | Kin Meds | $199/mo | $249/mo | Not disclosed | Not disclosed | — | medium |
| 15 | PauseRX | $199/mo | $249/mo | Not disclosed | 503A/B (unnamed) | — | medium |
| 16 | ShedRx | $199/mo | $299/mo | Not disclosed | Not disclosed | — | medium |
| 17 | Wisp | $225/mo | — | Not disclosed | Not disclosed | Certified | medium |
| 18 | Direct Meds | $249/mo | $399/mo | Not disclosed | Not disclosed | — | medium |
| 19 | GetRelief Rx | $269/mo | $179/mo | Not disclosed | Not disclosed | — | medium |
| 20 | Embody | $299/mo | $299/mo | Not disclosed | Not disclosed | — | medium |
| 21 | Amazon One Medical | — | — | All 50 | Not disclosed | — | high |
| 22 | AquaVita NextGen | — | — | 5 states | Not disclosed | — | medium |
| 23 | Calibrate Health | — | — | All 50 | Not disclosed | — | high |
| 24 | Good Girl Rx | — | — | Not disclosed | 503A/B (unnamed) | Certified | medium |
| 25 | GoodRx | — | — | All 50 | Not disclosed | — | high |
| 26 | HealthHub | — | — | Not disclosed | Yes (named) | ID 46103909 | medium |
| 27 | LillyDirect Foundayo | — | — | All 50 + DC | Not disclosed | — | high |
| 28 | MadeMed | — | — | Not disclosed | 503A/B (unnamed) | — | medium |
| 29 | Näky | — | — | Not disclosed | Not disclosed | — | medium |
| 30 | NowPatient | — | — | Not disclosed | Not disclosed | — | medium |
| 31 | Ro | — | — | Not disclosed | Not disclosed | — | medium |
| 32 | Wellorithm | — | — | 49 states | Not disclosed | — | medium |
How providers are classified as “oral”
A provider appears in this table if its description explicitly mentions any of: ODT, oral dissolving tablet, sublingual, troche, lozenge, buccal, oral tablet, tablet form, oral compounded, oral semaglutide, oral tirzepatide, oral GLP, orforglipron, Foundayo, or Rybelsus; OR if any pricing entry uses the compounded-oral form designation.
Related tables
- Master GLP-1 provider comparison matrix (all providers)
- Cheapest compounded semaglutide
- Best oral GLP-1 providers editorial ranking
- Best Foundayo (orforglipron) providers — the FDA-approved oral GLP-1
This page does not constitute medical advice. Compounded oral GLP-1 medications are not FDA-approved finished drug products and have a weaker evidence base than injectable equivalents. Consult a licensed clinician before starting any weight-management medication.